STA
EVH icon

Summit Trail Advisors’s Evolent Health EVH Stock Holding History

Summit Trail Advisors’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2,865
Closed -$60K – 340
2018
Q2 		$60K Buy
+2,865
New +$54.2K 0.02% 284
2018
Q1 		– Sell
-3,620
Closed -$52K – 820
2017
Q4 		$52K Buy
+3,620
New +$51K 0.01% 805

Other funds holding EVH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Summit Trail Advisors's EVH Position: Q3 2018 in Review

Summit Trail Advisors sold out of Evolent Health (EVH) in Q3 2018, closing a stake of 2,865 shares — an estimated $60K sold.

Summit Trail Advisors first reported a position in EVH in Q4 2017 and held it in 2 quarters. The position peaked at $60K in Q2 2018. 187 funds tracked by Wall St. Rank hold EVH as of Q3 2018.

  • Summit Trail Advisors reported no remaining Evolent Health position as of Q3 2018 after selling out during the quarter.
  • Summit Trail Advisors sold 2,865 Evolent Health shares in Q3 2018, an estimated $60K.
  • Summit Trail Advisors first reported a position in Evolent Health in Q4 2017 and held it in 2 quarters.
  • Summit Trail Advisors's Evolent Health position peaked at $60K in Q2 2018.
  • 187 funds tracked by Wall St. Rank held Evolent Health as of Q3 2018.

Based on Summit Trail Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.